Insider Selling: NeueHealth, Inc. (NYSE:NEUE) CEO Sells 31,798 Shares of Stock

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CEO George Lawrence Mikan III sold 31,798 shares of NeueHealth stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $233,079.34. Following the transaction, the chief executive officer now directly owns 146,539 shares of the company’s stock, valued at approximately $1,074,130.87. This represents a 17.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

George Lawrence Mikan III also recently made the following trade(s):

  • On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total value of $70,236.54.

NeueHealth Stock Performance

NEUE stock opened at $7.45 on Thursday. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $16.59. The firm has a market cap of $61.72 million, a P/E ratio of -0.15 and a beta of 0.57. The stock’s 50 day moving average price is $5.51 and its 200 day moving average price is $5.39.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada lowered their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

View Our Latest Report on NeueHealth

Institutional Trading of NeueHealth

A number of large investors have recently made changes to their positions in the stock. NEA Management Company LLC acquired a new position in NeueHealth in the 2nd quarter valued at about $14,834,000. Deer Management Co. LLC purchased a new stake in shares of NeueHealth during the second quarter worth about $5,436,000. Partners Group Holding AG purchased a new position in shares of NeueHealth during the third quarter valued at approximately $463,000. Finally, Renaissance Technologies LLC acquired a new stake in NeueHealth during the second quarter worth approximately $312,000. Institutional investors and hedge funds own 63.88% of the company’s stock.

About NeueHealth

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Further Reading

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.